• 5995 Citations
  • 47 h-Index
1995 …2022
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 49 Similar Profiles
Myelodysplastic Syndromes Medicine & Life Sciences
Acute Myeloid Leukemia Medicine & Life Sciences
Epigenomics Medicine & Life Sciences
Hematopoietic Stem Cells Medicine & Life Sciences
Hematopoiesis Medicine & Life Sciences
Stem Cells Medicine & Life Sciences
Stem cells Chemical Compounds
p38 Mitogen-Activated Protein Kinases Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2005 2022

Interleukin-8
Stem Cells
Therapeutics
Heterografts
Disease Progression
Firefighters
Hematologic Neoplasms
Dust
B-Cell Chronic Lymphocytic Leukemia
Paraproteinemias
Myelodysplastic Syndromes
Glutamine
Glutaminase
Therapeutics
Neoplasms
Myelodysplastic Syndromes
MicroRNAs
Therapeutics
Hematopoiesis
Stem Cells
Erythropoiesis
Myelodysplastic Syndromes
Erythroblasts
Anemia
GTP Phosphohydrolases

Publications 1995 2019

Hematopoietic Stem Cell Transplantation
Hematopoietic Stem Cells
Viruses
T-Lymphocytes
Tissue Donors

Activin receptor modulation

Mies, A., Verma, A. K. & Platzbecker, U., Jan 1 2018, Hematologic Malignancies. Springer Verlag, p. 97-104 8 p. (Hematologic Malignancies).

Research output: Chapter in Book/Report/Conference proceedingChapter

Activin Receptors
Hematinics
Erythroblasts
Erythropoietin
Anemia
1 Citation (Scopus)
Progressive Multifocal Leukoencephalopathy
Hematologic Neoplasms
Stem Cells
Transplants
Monoclonal Antibodies
11 Citations (Scopus)

Dual inhibition of MDMX and MDM2 as a therapeutic strategy in leukemia

Carvajal, L. A., Ben Neriah, D., Senecal, A., Benard, L., Thiruthuvanathan, V., Yatsenko, T., Narayanagari, S-R., Wheat, J. C., Todorova, T. I., Mitchell, K., Kenworthy, C., Guerlavais, V., Annis, D. A., Bartholdy, B. A., Will, B., Anampa Mesias, J. D., Mantzaris, I., Aivado, M., Singer, R. H., Coleman, R. A. & 2 othersVerma, A. K. & Steidl, U. G., Apr 11 2018, In : Science Translational Medicine. 10, 436, aao3003.

Research output: Contribution to journalArticle

Leukemia
Acute Myeloid Leukemia
Neoplasms
Therapeutics
Cell Cycle Checkpoints

Erratum to: Myelodysplastic syndrome progression to acute myeloid leukemia at the stem cell level (Nature Medicine, (2018), 10.1038/s41591-018-0267-4)

Chen, J., Kao, Y. R., Sun, D., Todorova, T. I., Reynolds, D., Narayanagari, S-R., Montagna, C., Will, B., Verma, A. K. & Steidl, U. G., Jan 1 2018, (Accepted/In press) In : Nature Medicine.

Research output: Contribution to journalArticle

HTML
Myelodysplastic Syndromes
Stem cells
Acute Myeloid Leukemia
Medicine